PHILADELPHIA —Integral Molecular, the leader in antibody discovery against membrane proteins, has been accepted into the U.S. Food & Drug Administration (FDA)’s ISTAND pilot program. This program supports Innovative Science and Technology Approaches for New Drugs and was created to expand the drug development tool types listed in the 21st Century Cures legislation. A major goal […]
Unterägeri, Switzerland _ SmartGene, a leading provider of bioinformatics Software-as-a-Service applications (SaaS Apps), today announced a new collaboration with Illumina, a global leader in DNA sequencing and array-based technologies, to enable broad adoption of Next Generation Sequencing (NGS) for routine analysis in infectious diseases and industrial markets. The scope of the collaboration includes clinical microbiology, food […]
This partnership will use whole human genome sequencing to support actionable characterisation of rare genetic diseases. Oxford Nanopore Technologies (Oxford Nanopore) and Al Jalila Children’s Specialty Hospital (AJCH) today announce a new partnership to investigate the potential utility of nanopore sequencing for children with unresolved rare genetic disorders. AJCH, the first and only dedicated children’s […]
Qingdao, Shenzhen — The 17th Annual Meeting of the International Conference on Genomics (ICG-17), a meeting point for leaders in the emerging field of Genomics to meet and share their experience and insights, is taking place on 5-7 September in Qingdao, China. At ICG-17, MGI introduces its mass production base of its latest miniaturized gene […]
Alan Lockley joins as Director of Global Services, Edward Quinn as Director of Product Development and Mark Appleton takes new role as Director of Research London, UK — H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimisation, safety, and scale-up, today announced three key appointments to the Company’s senior leadership […]
Large multi-site COVID-19 study to use IsoPlexis Single Cell Functional Proteomics to survey immunity. BRANFORD, Conn. — IsoPlexis (NASDAQ: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced a partnership with MediMergent, LLC, and The Center for Cancer and Blood Disorders (CCBD), an American Oncology Partners of […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN), today received a decision from the European Commission prohibiting the company’s acquisition of GRAIL. The company is reviewing the Commission’s order and intends to appeal the decision. The EC decision follows last week’s ruling by US Federal Trade Commission judge in favor of Illumina’s acquisition of GRAIL. “We are disappointed with […]
Singulator™ 100 System and components to be available through local distributor in Norway, Finland, Denmark and Sweden. LIVERMORE, Calif. — S2 Genomics, Inc. today announced that it has entered into a distribution agreement with Techtum Lab AB for the promotion, sales, and support of S2 Genomics’ Singulator™ 100 System and associated products for single-cell genomics […]
Wehrheim, Germany – MGI Tech Co. Ltd. (MGI), a global life science leader and innovator, has announced the commercial availability of its innovative HotMPS reagents* and sequencing instrument** in Germany as of 9 August 2022. “We are delighted to be bringing our proven DNBSEQ™ technology to customers and partners in Germany once again,” said Dr. […]
genOway to acquire exclusive rights to MilliporeSigma’s foundational genome-editing patents to produce, sell rodent models New technologies and solutions to be developed using CRISPR/Cas9 to accelerate delivery of better drugs to patients Update: September 6, 2022 – Learn about our expanded CRISPR/CAS9 Strategic Alliance here. Burlington, Massachusetts, December 10, 2018 — MilliporeSigma, a leader in genome editing, today […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
